Point-of-care biosensor systems for cancer diagnostics/prognostics

Area of Science:

• Oncology
• Biomedical Engineering
• Molecular Diagnostics

Background:

• Cancer-related diseases cause numerous fatalities, demanding advanced diagnostic and prognostic tools.
• Effective cancer management requires comprehensive molecular profiling beyond single markers.
• Current biosensor technology, often single-analyte, has limitations for complex cancer profiling.

Purpose of the Study:

• To review current molecular profiling strategies for cancer diagnosis and prognosis.
• To assess the state-of-the-art in biosensor technology for oncology.
• To propose new biosensor strategies for multi-analyte cancer profiling.

Main Methods:

• Literature review of molecular profiling techniques in cancer.
• Analysis of current biosensor applications and limitations in cancer diagnostics.
• Exploration of novel biosensor designs for multiplexed biomarker detection.

Main Results:

• Molecular profiling necessitates evaluating multiple biomarkers across DNA, RNA, and protein levels.
• Classical biosensors are insufficient due to their single-element detection capabilities.
• Advanced biosensor formats are needed to address the complexity of cancer molecular signatures.

Conclusions:

• New biosensor strategies are essential for comprehensive molecular profiling in cancer.
• Multiplexed biosensing platforms can significantly aid in cancer diagnosis and prognosis.
• Bridging biosensor technology and cancer research is crucial for clinical advancement.